We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+472.96%
AUM
$511B
AUM Growth
+$21.9B
Cap. Flow
+$7.52B
Cap. Flow %
1.47%
Top 10 Hldgs %
16.29%
Holding
6,226
New
458
Increased
2,669
Reduced
2,117
Closed
420

Top Sells

Rank Stock Value
1
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$3.61B
2
OXY icon
Occidental Petroleum
OXY
+$1.36B
3
MRK icon
Merck
MRK
+$913M
4
V icon
Visa
V
+$801M
5
T icon
AT&T
T
+$771M

Sector Composition

Rank Sector Weight
1 Technology 12.6%
2 Financials 12.17%
3 Healthcare 9.21%
4 Consumer Discretionary 8.57%
5 Industrials 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORTX
5876
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
-3
Closed -$1K
MRTX
5877
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-146,300
Closed -$10.7M
ONCT
5878
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
-9
Closed -$1K
FTCH
5879
PUT
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-150,000
Closed -$4.04M
NM
5880
DELISTED
Navios Maritime Holdings Inc.
NM
$0 ﹤0.01%
107
-2,701
-96% -$10.2K
APRN
5881
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$0 ﹤0.01%
+4
New +$581
ICPT
5882
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-7,100
Closed -$794K
ICPT
5883
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-122,300
Closed -$13.7M
SVVC
5884
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
-2,966
Closed -$39K
SYNH
5885
CALL
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-14,100
Closed -$730K
SYNH
5886
PUT
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-97,200
Closed -$5.03M
ACGN
5887
DELISTED
Aceragen Inc
ACGN
-4,173
Closed -$181K
OFED
5888
DELISTED
Oconee Federal Financial Corp.
OFED
-442
Closed -$11K
NMTR
5889
DELISTED
9 Meters Biopharma
NMTR
-263
Closed -$10K
MGI
5890
DELISTED
MoneyGram International, Inc. New
MGI
-7,533
Closed -$15K
SEAC
5891
DELISTED
Seachange International Inc
SEAC
-11,220
Closed -$298K
TA
5892
DELISTED
TravelCenters of America LLC
TA
-16,168
Closed -$332K
BBBY
5893
CALL
DELISTED
Bed Bath & Beyond Inc
BBBY
-50,000
Closed -$850K
BBBY
5894
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
-981,200
Closed -$16.7M
VVNT
5895
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
-229
Closed -$2K
AVYA
5896
CALL
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
-6,000
Closed -$101K
VIVE
5897
DELISTED
VIVEVE MED INC
VIVE
0
ABMD
5898
CALL
DELISTED
Abiomed Inc
ABMD
-40,000
Closed -$11.4M
NH
5899
DELISTED
NantHealth, Inc
NH
$0 ﹤0.01%
25
-19,967
-100% -$203K
SECO
5900
DELISTED
Secoo Holding Limited ADR
SECO
-1,757
Closed -$154K

Similar funds

JP Morgan Chase's Q2 2019 Portfolio in Review

As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

JP Morgan Chase's Q2 2019 filing shows 458 new, 2,669 increased, 2,117 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

  • JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
  • JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
  • JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
  • JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
  • JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
  • JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
  • JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.

Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.